Results 1 to 20 of 21
Page 1 of 2  Next >
TypeTitleAuthor(s)YearViews
Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive, nucleoside-naive patients treated with entecavirGish, RG; Chang, TT; Lai, CL; de Man, RA; Gadano, A; Llamoso, C; Tang, H201348
 
Decline in hepatitis B surface antigen levels with entecavir treatment in HBeAg-positive nucleoside naive chronic hepatitis B patients-results from phase III study ETV-022Gish, R; Chang, TT; Lai, CL; De Man, RA; Gadano, A; Yu, S; Llamoso, C; Tang, H201272
 
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis BGish, RG; Chang, TT; Lai, CL; De Man, R; Gadano, A; Poordad, F; Yang, J; BrettSmith, H; Tamez, R2010313
 
Efficacy of entecavir in chronic hepatitis b patients with mildly elevated alanine aminotransferase and biopsy-proven histological damageWu, IC; Lai, CL; Bui Han, SH; Han, KH; Gordon, SC; Chao, YC; Tan, CK; Sievert, W; Tanwandee, T; Xu, D; Neo, BL; Chang, TT201086
 
Entecavir treatment for up to 5 years in patients with hepatitis b e antigen-positive chronic hepatitis BChang, TT; Lai, CL; Yoon, SK; Lee, SS; Coelho, HSM; Carrilho, FJ; Poordad, F; Halota, W; Horsmans, Y; Tsai, N; Zhang, H; Tenney, DJ; Tamez, R; Iloeje, U2010147
 
Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis BChang, TT; Liaw, YF; Wu, SS; Schiff, E; Han, KH; Lai, CL; Safadi, R; Lee, SS; Halota, W; Goodman, Z; Chi, YC; Zhang, H; Hindes, R; Iloeje, U; Beebe, S; Kreter, B2010130
 
Long-term entecavir treatment for up to 5 years in Asians with HBEAG-positive nucleos(T)ide naïve chronic hepatitis B: results from ETV-022 and -901Pan, C; Tong, MJ; Kowdley, KV; Hu, KQ; Chang, TT; Lai, CL; Yoon, SK; Lee, SS; Cohen, DS; Tang, H; Tsai, N2010140
 
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapyShouval, D; Lai, CL; Chang, TT; Cheinquer, H; Martin, P; Carosi, G; Han, S; Kaymakoglu, S; Tamez, R; Yang, J; Tenney, D; BrettSmith, H2009116
 
Efficacy of entecavir in nucleoside-naefve patients with mildly elevated ALTGordon, SC; Han, SH; Chang, TT; Lai, CL; Han, KH; Chao, YC; Tan, CK; Sievert, W; Tanwandee, T; Neo, BL2008108
 
Three years of entecavir (etv) re-treatment of HBeAg(-) etv patients who previously discontinued ETV treatment: results from study ETV-901Shouval, D; Lai, CL; Chang, TT; Gadano, A; Wu, SS; Halota, W; Sievert, W; Tsai, NCSC; Zhang, H; Iloeje, U2008148
 
Long-term entecavir therapy results in reversal of fibrosis/cirrhosis and continued histologic improvement in patients with HBeAg(+) and (-) chronic hepatitis B: results from studies ETV-022, -027 and -901.Liaw, YF; Chang, TT; Wu, SS; Schiff, ER; Han, KH; Lai, CL; Safadi, R; Lee, SS; Halota, W; Goodman, ZD; Zhang, H; Hindes, R; Hoeje, U; Beebe, S; Kreter, B2008202
 
Continued virologic and biochemical improvement through 96 weeks of entecavir treatment in HBeAg(?) chronic hepatitis B patients (study ETV-027)Shouval, D; Akarca, US; Hatzis, G; Kitis, G; Lai, CL; Cheinquer, H; Chang, TT; Zink, R; Zhu, J; Brett-Smith, H200690
 
Continued Virologic Improvement Through 96 Weeks of Entecavir Treatment in HBeAg(-) Chronic Hepatitis B Patients (Study ETV-027)Poordad, F; Dieterich, DT; Min, AD; Shouval, D; Lai, CL; Cheinquer, H; Chang, TT; Zink, R; Zhu, J; Brett-Smith, H200696
 
Hepatitis B virus with primary resistance to adefovir [11]Chang, TT; Lai, CL2006120
 
Hepatitis B Surface Antigen Loss in Antiviral-treated Patients with HBeAg(+) Chronic Hepatits B (CHB) Infection: Observations from Antiviral-naive Patients Treated with Entecavir (ETV) or lamivudine (LVD)Gish, R; Chang, TT; Lai, CL; de Man, R; Gadano, A; Poordad, F; Zhu, J; Yang, J; Brett-Smith, H2006108
 
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis BLai, CL; Shouval, D; Lok, AS; Chang, TT; Cheinquer, H; Goodman, Z; DeHertogh, D; Wilber, R; Zink, RC; Cross, A; Colonno, R; Fernandes, L2006392
 
Four years of lamivudine treatment in Chinese patients with chronic hepatitis BChang, TT; Lai, CL; Chien, RN; Guan, R; Lim, SG; Lee, CM; Ng, KY; Nicholls, GJ; Dent, JC; Leung, NWY2004137
 
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapyLeung, NWY; Lai, CL; Chang, TT; Guan, R; Lee, CM; Ng, KY; Lim, SG; Wu, PC; Dent, JC; Edmundson, S; Condreay, LD; Chien, RN200183
 
Effects of extended lamivudine therapy in asian patients with chronic hepatitis BLiaw, YF; Leung, NWY; Chang, TT; Guan, R; Tai, DI; Ng, KY; Chien, RN; Dent, J; Roman, L; Edmundson, S; Lai, CL200068
 
A one-year trial of lamivudine for chronic hepatitis BLai, CL; Chien, RN; Leung, NWY; Chang, TT; Guan, R; Tai, DI; Ng, KY; Wu, PC; Dent, JC; Barber, J; Stephenson, SL; Gray, DF1998314
 
Page 1 of 2  Next >
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download